F
Farmacosmo SpA
MIL:COSMO
Farmacosmo SpA
MIL:COSMO
Price:
0.488
EUR
0.21%
Market Closed
Market Cap:
€17m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
Farmacosmo SpA
MIL:COSMO
|
IT |
|
Rivian Automotive Inc
F:99U
|
US |
|
S
|
Sanofi SA
BMV:SNYN
|
FR |
Balance Sheet
Balance Sheet Decomposition
Farmacosmo SpA
Farmacosmo SpA
Balance Sheet Decomposition is not available for
Farmacosmo SpA
Farmacosmo SpA
Balance Sheet
Farmacosmo SpA
Farmacosmo SpA
Currency: EUR
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1
|
2
|
1
|
7
|
5
|
3
|
|
| Cash |
1
|
2
|
1
|
7
|
5
|
3
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
3
|
5
|
6
|
10
|
7
|
5
|
|
| Accounts Receivables |
2
|
4
|
5
|
10
|
5
|
4
|
|
| Other Receivables |
0
|
0
|
1
|
0
|
2
|
1
|
|
| Inventory |
1
|
1
|
2
|
5
|
7
|
9
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Assets |
4
|
8
|
9
|
22
|
20
|
18
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
1
|
1
|
1
|
5
|
5
|
4
|
|
| Goodwill |
0
|
0
|
0
|
11
|
11
|
8
|
|
| Note Receivable |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
11
|
11
|
8
|
|
| Total Assets |
5
N/A
|
9
+82%
|
11
+24%
|
39
+264%
|
36
-7%
|
31
-15%
|
|
| Liabilities | |||||||
| Accounts Payable |
4
|
7
|
8
|
15
|
12
|
10
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
2
|
1
|
1
|
|
| Total Current Liabilities |
4
|
8
|
9
|
19
|
15
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
5
|
7
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
2
|
2
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Liabilities |
4
N/A
|
8
+85%
|
10
+20%
|
22
+123%
|
23
+8%
|
20
-14%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
3
|
3
|
3
|
|
| Retained Earnings |
0
|
0
|
1
|
0
|
4
|
7
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
14
|
14
|
14
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
+45%
|
1
+75%
|
17
+1 700%
|
13
-26%
|
11
-18%
|
|
| Total Liabilities & Equity |
5
N/A
|
9
+82%
|
11
+24%
|
39
+264%
|
36
-7%
|
31
-15%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
33
|
33
|
33
|
38
|
39
|
39
|
|
Switch to:
Switch to:
See Also
Discover More
